UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q


☑			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended ~~April~~October 3031, 2025


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to

~~BRADY~~Commission ~~CORPORATION~~File Number 1-14959

BRADY CORPORATION

(Exact name of registrant as specified in its charter)


Wisconsin						39-0178960
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

6555 West Good Hope Road

Milwaukee, Wisconsin 53223

(Address of principal executive offices and zip code)

(414) 358-6600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol	Name of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per share	BRC	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,"” and "“emerging growth company"” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☑

Accelerated filer

☐

Emerging growth company

☐

Non-accelerated filer

☐

Smaller reporting company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

As of ~~May~~November 1413, 2025, there were 43,~~776~~638,~~968~~096 outstanding shares of Class A Nonvoting Common Stock and 3,538,628 shares of Class B Voting Common Stock. The Class B Voting Common Stock, all of which is held by affiliates of the Registrant, is the only voting stock.

Table of Contents

INDEX

			Page
PART I. Financial Information			3
Item 1. Financial Statements (Unaudited)			3
Condensed Consolidated Balance Sheets			3
Condensed Consolidated Statements of Income			4
Condensed Consolidated Statements of Comprehensive Income			5
Condensed Consolidated Statements of Stockholders' Equity			6
Condensed Consolidated Statements of Stockholders’ Equity			6
Condensed Consolidated Statements of Cash Flows			87
Notes to Condensed Consolidated Financial Statements			98
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			18
Item 3. Quantitative and Qualitative Disclosures About Market Risk			2524
Item 4. Controls and Procedures			2524
PART II. Other Information			2625
Item 1. Legal Proceedings			2625
Item 1A. Risk Factors			2625
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			2625
Item 5. Other Information			2625
Item 6. Exhibits			2726
Signatures			2827

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)

	April 30, 2025		July 31, 2024
	October 31, 2025		July 31, 2025
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	~~152~~182,~~154~~684	$	~~250~~174,~~118~~349
Accounts receivable, net of allowance for credit losses of $8,967 and $6,749, respectively	224,358		185,486
Accounts receivable, net of allowance for credit losses of $7,253 and $7,876, respectively	248,551		231,944
Inventories	~~189~~215,~~991~~568		~~152~~200,~~729~~881
Prepaid expenses and other current assets	15,~~399~~568		1114,~~382~~661
Total current assets	~~581~~662,~~902~~371		~~599~~621,~~715~~835
Property, plant and equipment—net	~~219~~232,~~082~~522		~~195~~225,~~758~~572
Goodwill	~~682~~681,~~554~~721		~~589~~676,~~611~~945
Other intangible assets	~~111~~114,~~685~~932		51105,~~839~~374
Deferred income taxes	2018,~~583~~495		1520,~~596~~862
Operating lease assets	5860,~~118~~350		3858,~~504~~422
Other assets	24,~~191~~283		2425,~~546~~243
Total	$	1,~~698~~794,~~115~~674	$	1,~~515~~734,~~569~~253
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	99103,~~754~~804	$	84105,~~691~~028
Accrued compensation and benefits	8769,~~506~~886		7792,~~954~~657
Taxes, other than income taxes	1922,~~711~~933		1421,~~061~~537
Accrued income taxes	26,~~976~~812		75,~~424~~547
Current operating lease liabilities	1516,~~030~~590		1315,~~382~~234
Other current liabilities	86100,~~809~~683		6790,~~170~~329
Total current liabilities	~~311~~320,~~786~~708		~~264~~330,~~682~~332
Long-term debt	~~102~~115,~~819~~906		9099,~~935~~766
Long-term operating lease liabilities	4344,~~772~~288		2543,~~342~~565
Other liabilities	7268,~~185~~952		6768,~~952~~379
Total liabilities	~~530~~549,~~562~~854		~~448~~542,~~911~~042
Stockholders’ equity:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 43,774,580 and 44,042,462 shares, respectively	513		513
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 43,666,121 and 43,530,012 shares, respectively	513		513
Class B voting common stock—Issued and outstanding, 3,538,628 shares	35		35
Additional paid-in capital	~~357~~359,~~545~~690		~~353~~359,~~654~~269
Retained earnings	1,~~279~~360,~~168~~156		1,~~174~~317,~~025~~739
Treasury stock—7,486,907 and 7,219,025 shares, respectively, of Class A nonvoting common stock, at cost	(375,974)		(351,947)
Treasury stock—7,595,366 and 7,731,475 shares, respectively, of Class A nonvoting common stock, at cost	(388,847)		(393,186)
Accumulated other comprehensive loss	(9386,~~734~~727)		(~~109~~92,~~622~~159)
Total stockholders’ equity	1,~~167~~244,~~553~~820		1,~~066~~192,~~658~~211
Total	$	1,~~698~~794,~~115~~674	$	1,~~515~~734,~~569~~253

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Dollars in Thousands, Except Per Share Amounts, Unaudited)

Three months ended April 30,

Nine months ended April 30,

Three months ended October 31,

2025

2024

~~2025~~

~~2024~~

Net sales

~~382~~405,~~590~~287

~~343~~377,~~384~~065

~~1,116,330~~

~~997,991~~

Cost of goods sold

~~187~~196,~~531~~455

~~166~~187,~~357~~376

~~555,739~~

~~487,162~~

Gross margin

~~195~~208,~~059~~832

~~177~~189,~~027~~689

~~560,591~~

~~510,829~~

Operating expenses:

Research and development

1923,~~191~~292

1718,~~681~~921

~~56,835~~

~~50,215~~

Selling, general and administrative

~~108~~117,~~678~~568

95111,~~803~~846

~~326,410~~

~~283,415~~

Total operating expenses

~~127~~140,~~869~~860

~~113~~130,~~484~~767

~~383,245~~

~~333,630~~

Operating income

67,~~190~~972

6358,~~543~~922

~~177,346~~

~~177,199~~

Other (expense) income:

Other income (expense):

Investment and other (expense) income

(509)

1,596

2,850

4,718

Investment and other income

1,712

1,234

Interest expense

(~~936~~1,208)

(~~728~~1,356)

~~(3,604)~~

~~(2,284)~~

Income before income taxes

6568,~~745~~476

6458,~~411~~800

~~176,592~~

~~179,633~~

Income tax expense

1314,~~482~~540

1312,~~521~~017

~~37,212~~

~~37,874~~

Net income

5253,~~263~~936

5046,~~890~~783

~~139,380~~

~~141,759~~

Net income per Class A Nonvoting Common Share:

Basic

1.1014

10.0698

~~2.92~~

~~2.94~~

Diluted

1.0913

10.0597

~~2.89~~

~~2.91~~

Net income per Class B Voting Common Share:

Basic

1.1013

10.0696

~~2.90~~

~~2.92~~

Diluted

1.0911

10.0595

~~2.88~~

~~2.90~~

Weighted average common shares outstanding:

Basic

47,~~644~~273

4847,~~004~~732

~~47,743~~

~~48,294~~

Diluted

4847,~~066~~731

48,~~386~~217

~~48,196~~

~~48,640~~

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Dollars in Thousands, Unaudited)

Three months ended April 30,

Nine months ended April 30,

Three months ended October 31,

2025

2024

~~2025~~

~~2024~~

Net income

5253,~~263~~936

5046,~~890~~783

~~139,380~~

~~141,759~~

Other comprehensive income (loss):

Foreign currency translation adjustments

384,~~161~~743

(~~6,537~~79)

~~16,902~~

~~(12,310)~~

Cash flow hedges:

Net (loss) gain recognized in other comprehensive income (loss)

(423)

447

(826)

1,236

Net gain (loss) recognized in other comprehensive income (loss)

621

(1,338)

Reclassification adjustment for losses (gains) included in net income

~~210~~296

(~~173~~464)

~~209~~

~~(1,712)~~

(213)

274

(617)

(476)

917

(1,802)

Pension and other post-retirement benefits actuarial gain amortization

(~~152~~151)

~~(454)~~

Other comprehensive income (loss), before tax

375,~~796~~509

(62,~~415~~032)

~~15,831~~

~~(13,240)~~

Income tax benefit (expense) related to items of other comprehensive income (loss)

297

(51)

(106)

Income tax (expense) benefit related to items of other comprehensive (loss) income

(77)

Other comprehensive income (loss), net of tax

385,~~093~~432

(61,~~466~~980)

~~15,888~~

~~(13,346)~~

Comprehensive income

9059,~~356~~368

44,~~424~~803

~~155,268~~

~~128,413~~

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS'’ EQUITY

(Dollars in Thousands, Unaudited)

	Three months ended April 30, 2025
	Three months ended October 31, 2025
	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders'’ Equity
Balances at January 31, 2025	$	548	$	356,531	$	1,238,275	$	(343,059)	$	(131,827)	$	1,120,468
Balances at July 31, 2025	$	548	$	359,269	$	1,317,739	$	(393,186)	$	(92,159)	$	1,192,211
Net income	—		—		5253,~~263~~936		—		—		5253,~~263~~936
Other comprehensive income, net of tax	—		—		—		—		385,~~093~~432		385,~~093~~432
Issuance of shares of Class A Common Stock under stock plan	—		(~~755~~6,591)		—		~~415~~8,393		—		~~(340)~~1,802
Stock-based compensation expense	—		1,769		—		—		—		1,769
Tax benefit and withholdings from deferred compensation distributions	—		266		—		—		—		266
Repurchase of shares of Class A Common Stock, including excise taxes	—		—		—		(33,330)		—		(33,330)
Stock-based compensation expense	—		6,746		—		—		—		6,746
Repurchase of shares of Class A Common Stock, including excise taxes	—		—		—		(4,054)		—		(4,054)
Cash dividends on Common Stock:
Class A — $0.2400 per share	—		—		(10,521)		—		—		(10,521)
Class A — $0.2450 per share	—		—		(10,711)		—		—		(10,711)
Class B — $0.2400 per share	—		—		(849)		—		—		(849)
Class B — $0.2284 per share	—		—		(808)		—		—		(808)
Balances at April 30, 2025	$	548	$	357,545	$	1,279,168	$	(375,974)	$	(93,734)	$	1,167,553
Balances at October 31, 2025	$	548	$	359,690	$	1,360,156	$	(388,847)	$	(86,727)	$	1,244,820

	Nine months ended April 30, 2025
	Three months ended October 31, 2024
	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders'’ Equity
Balances at July 31, 2024	$	548	$	353,654	$	1,174,025	$	(351,947)	$	(109,622)	$	1,066,658
Net income	—		—		~~139~~46,~~380~~783		—		—		~~139~~46,~~380~~783
Other comprehensive income, net of tax	—		—		—		—		15,888		15,888
Other comprehensive loss, net of tax	—		—		—		—		(1,980)		(1,980)
Issuance of shares of Class A Common Stock under stock plan	—		(65,~~061~~065)		—		97,~~303~~935		—		32,~~242~~870
Tax benefit and withholdings from deferred compensation distributions	—		190		—		—		—		190
Stock-based compensation expense	—		95,~~762~~813		—		—		—		95,~~762~~813
Repurchase of shares of Class A Common Stock, including excise taxes	—		—		—		(33,330)		—		(33,330)
Cash dividends on Common Stock:
Class A — $0.7200 per share	—		—		(31,749)		—		—		(31,749)
Class A — $0.2400 per share	—		—		(10,612)		—		—		(10,612)
Class B — $0.7034 per share	—		—		(2,488)		—		—		(2,488)
Class B — $0.2234 per share	—		—		(790)		—		—		(790)
Balances at April 30, 2025	$	548	$	357,545	$	1,279,168	$	(375,974)	$	(93,734)	$	1,167,553
Balances at October 31, 2024	$	548	$	354,592	$	1,209,406	$	(344,012)	$	(111,602)	$	1,108,932

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

	Three months ended April 30, 2024
	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at January 31, 2024	$	548	$	353,794	$	1,090,045	$	(305,714)	$	(99,941)	$	1,038,732
Net income	—		—		50,890		—		—		50,890
Other comprehensive loss, net of tax	—		—		—		—		(6,466)		(6,466)
Issuance of shares of Class A Common Stock under stock plan	—		(521)		—		436		—		(85)
Stock-based compensation expense	—		1,159		—		—		—		1,159
Repurchase of shares of Class A Common Stock, including excise taxes	—		—		—		(50,932)		—		(50,932)
Cash dividends on Common Stock:
Class A — $0.2350 per share	—		—		(10,364)		—		—		(10,364)
Class B — $0.2350 per share	—		—		(832)		—		—		(832)
Balances at April 30, 2024	$	548	$	354,432	$	1,129,739	$	(356,210)	$	(106,407)	$	1,022,102

	Nine months ended April 30, 2024
	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Total Stockholders' Equity
Balances at July 31, 2023	$	548	$	351,771	$	1,021,870	$	(290,209)	$	(93,061)	$	990,919
Net income	—		—		141,759		—		—		141,759
Other comprehensive loss, net of tax	—		—		—		—		(13,346)		(13,346)
Issuance of shares of Class A Common Stock under stock plan	—		(3,910)		—		6,829		—		2,919
Tax benefit and withholdings from deferred compensation distributions	—		149		—		—		—		149
Stock-based compensation expense	—		6,422		—		—		—		6,422
Repurchase of shares of Class A Common Stock, including excise taxes	—		—		—		(72,830)		—		(72,830)
Cash dividends on Common Stock:
Class A — $0.7050 per share	—		—		(31,454)		—		—		(31,454)
Class B — $0.6884 per share	—		—		(2,436)		—		—		(2,436)
Balances at April 30, 2024	$	548	$	354,432	$	1,129,739	$	(356,210)	$	(106,407)	$	1,022,102

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in Thousands, Unaudited)

	Nine months ended April 30,
	Three months ended October 31,
	2025		2024
Operating activities:
Net income	$	~~139~~53,~~380~~936	$	~~141~~46,~~759~~783
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3011,~~279~~008		2210,~~406~~164
Stock-based compensation expense	96,~~762~~746		65,~~422~~813
Deferred income taxes	(63,~~038)~~973		(~~6,902~~903)
Other	~~(181)~~223		~~1,358~~(880)
Changes in operating assets and liabilities:
Accounts receivable	(612,~~869~~875)		(154,~~915~~385)
Inventories	(810,~~209~~980)		20(2,~~861~~107)
Prepaid expenses and other assets	(~~3,754~~391)		(1,~~849~~136)
Accounts payable and accrued liabilities	(2619,~~415~~530)		7(33,~~347~~960)
Income taxes	(51,~~081)~~246		(4,~~393)~~017
Net cash provided by operating activities	~~122~~33,~~874~~356		~~171~~23,~~094~~406
Investing activities:
Purchases of property, plant and equipment	(1810,~~685~~980)		(697,~~157~~286)
Acquisition of businesses, net of cash acquired	(~~147~~17,~~248~~416)		—(140,625)
Other	~~854~~8		~~(1,174)~~10
Net cash used in investing activities	(~~165~~28,~~079~~388)		(70147,~~331~~901)
Financing activities:
Payment of dividends	(3411,~~237~~519)		(3311,~~890~~402)
Proceeds from exercise of stock options	5,~~759~~001		5,~~583~~855
Payments for employee taxes withheld from stock-based awards	(23,~~518~~198)		(2,~~664~~090)
Purchase of treasury stock	(334,~~155~~054)		~~(72,225)~~—
Proceeds from borrowing on credit agreement	~~206~~46,~~249~~640		~~111~~135,~~790~~149
Repayment of borrowing on credit agreement	(~~194~~30,~~365~~500)		(97109,~~732~~439)
Other	~~190~~266		~~149~~190
Net cash used in financing activities	(52,077)		(88,989)
Net cash provided by financing activities	2,636		18,263
Effect of exchange rate changes on cash and cash equivalents	~~(3,682)~~731		(21,~~848)~~775
Net (decrease) increase in cash and cash equivalents	(97,964)		8,926
Net increase (decrease) in cash and cash equivalents	8,335		(104,457)
Cash and cash equivalents, beginning of period	~~250~~174,~~118~~349		~~151~~250,~~532~~118
Cash and cash equivalents, end of period	$	~~152~~182,~~154~~684	$	~~160~~145,~~458~~661

See Notes to Condensed Consolidated Financial Statements.

Table of Contents

BRADY CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~Nine~~Three Months Ended ~~April~~October 3031, 2025

(Unaudited)

(In thousands, except share and per share amounts)

NOTE A — Basis of Presentation

The condensed consolidated financial statements included herein have been prepared by Brady Corporation and subsidiaries (the “Company,” “Brady,” “we,” or “our”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of the Company, the foregoing statements contain all adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial position of the Company as of ~~April~~October 3031, 2025 and July 31, ~~2024~~2025, its results of operations, cash flows and comprehensive income for the three ~~and nine~~ months ended ~~April~~October 3031, 2025 and 2024~~, and cash flows for the nine months ended April 30, 2025 and 2024~~. The condensed consolidated balance sheet as of July 31, ~~2024~~2025 has been derived from the audited consolidated financial statements as of that date. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts therein. Due to the inherent uncertainty involved in making estimates, actual results in future periods may differ from the estimates.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to rules and regulations of the Securities and Exchange Commission. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentation. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended July 31, ~~2024~~2025.

NOTE B — New Accounting Pronouncements

Adopted Standards

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The guidance requires expanded interim and annual disclosures of segment information including the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within segment profit and loss. The Company adopted ASU 2023-07 for the year ended July 31, 2025, with retrospective application of the expanded segment information for the years ended July 31, 2024 and 2023. Additional information regarding the Company’s reportable segments, including the application of the provisions of ASU 2023-07 for the three months ended October 31, 2025 and 2024, is included in Note H to the condensed consolidated financial statements.

Standards not yet adopted

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The guidance requires expanded interim and annual disclosures of segment information including the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within segment profit and loss. The guidance is effective for the Company's fiscal 2025 Form 10-K and interim periods thereafter. The Company is currently assessing its segment information disclosures in connection with the adoption of ASU 2023-07.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The guidance requires expanded annual disclosures including the standardization and disaggregation of income tax rate reconciliation categories and the amount of income taxes paid by jurisdiction. The guidance is effective for the Company’s fiscal 2026 Form 10-K. The Company is currently assessing its income tax disclosures in connection with the adoption of ASU 2023-09.

In November 2024, the FASB issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” The guidance requires expanded interim and annual disclosures of expense information including the amounts of inventory purchases, employee compensation, depreciation, amortization, and depletion within commonly presented expense captions during the period. The guidance is effective for the Company'’s fiscal 2028 Form 10-K and interim periods thereafter. The Company is currently evaluating the ASU to determine ~~its~~the impact this guidance will have on the Company'’s disclosures.

Table of Contents

NOTE C — Additional Balance Sheet Information

Inventories

Inventories consisted of the following as of ~~April~~October 3031, 2025 and July 31, ~~2024~~2025:

	April 30, 2025		July 31, 2024
	October 31, 2025		July 31, 2025
Finished products	$	~~104~~114,~~559~~828	$	89109,~~430~~726
Work-in-process	2938,~~332~~189		2432,~~601~~787
Raw materials and supplies	5662,~~100~~551		3858,~~698~~368
Total inventories	$	~~189~~215,~~991~~568	$	~~152~~200,~~729~~881

Property, plant and equipment

Property, plant and equipment is presented net of accumulated depreciation ~~in the amount~~ of $~~309~~316,~~349~~274 and $~~304~~313,~~199~~778 as of ~~April~~October 3031, 2025 and July 31, ~~2024~~2025, respectively.

NOTE D — Other Intangible Assets

Other intangible assets as of ~~April~~October 3031, 2025 and July 31, ~~2024~~2025 consisted of the following:

April 30, 2025

July 31, 2024

October 31, 2025

July 31, 2025

Weighted Average Amortization Period (Years)

Gross Carrying Amount

Accumulated Amortization

Net Book Value

Weighted Average Amortization Period (Years)

Gross Carrying Amount

Accumulated Amortization

Net Book Value

Amortized other intangible assets:

Tradenames

~~911~~925

(~~342~~578)

~~569~~347

~~600~~912

(~~600~~456)

—456

Customer relationships

~~126~~138,~~148~~275

(3442,~~778~~759)

9195,~~370~~516

64125,~~430~~497

(2338,~~279~~427)

4187,~~151~~070

Technology

2118,~~500~~808

(97,~~411~~413)

1211,~~089~~395

920,~~300~~471

(610,~~182~~275)

310,~~118~~196

Unamortized other intangible assets:

Tradenames

N/A

7,~~657~~674

—

7,~~657~~674

N/A

7,~~570~~652

—

7,~~570~~652

Total

~~156~~165,~~216~~682

(4450,~~531~~750)

~~111~~114,~~685~~932

81154,~~900~~532

(3049,~~061~~158)

51105,~~839~~374

The change in the gross carrying amount of other intangible assets as of ~~April~~October 3031, 2025 compared to July 31, ~~2024~~2025 was primarily due to the ~~acquisitions~~acquisition of ~~Gravotech~~MECCO ~~Holding~~Partners ~~(“Gravotech”),~~LLC ~~American Barcode and RFID Incorporated~~ (“~~AB&R~~Mecco”), ~~and the Microfluidic Solutions business unit of Funai Electric Co., Ltd. (“Microfluidic Solutions”)~~ completed during the ~~nine~~three months ended ~~April~~October 3031, 2025, ~~and~~partially tooffset aby ~~lesser extent,~~ the ~~effect~~removal of ~~currency~~a ~~fluctuations~~fully amortized technology asset. Refer to Note NO, “Acquisitions,” for additional information on intangible assets acquired.

Amortization expense on intangible assets was $45,~~754~~341 and $24,~~365~~713 for the three months ended ~~April~~October 3031, 2025 and 2024, respectively~~, and $14,138 and $7,084 for the nine months ended April 30, 2025 and 2024, respectively~~.

NOTE E — Leases

The Company leases certain manufacturing facilities, warehouse and office spaces, and vehicles accounted for as operating leases. Lease terms typically range from one year to ten years. As of ~~April~~October 3031, 2025, the Company did not have any finance leases.

Operating lease expense was $45,~~714~~222 and $34,~~688~~735 for the three months ended ~~April~~October 3031, 2025 and 2024, respectively, ~~and $13,988 and $11,557 for the nine months ended April 30, 2025 and 2024, respectively,~~ which was recognized in either “Cost of goods sold” or “Selling, general and administrative” expenses in the condensed consolidated statements of income, based on the nature of the lease. Short-term lease expense, variable lease expenses, and sublease income were immaterial to the condensed consolidated statements of income for the three ~~and nine~~ months ended ~~April~~October 3031, 2025 and 2024.

109

Table of Contents

Supplemental cash flow information related to the Company'’s operating leases for the ~~nine~~three months ended ~~April~~October 3031, 2025 and 2024 was as follows:

	Nine months ended April 30,
	Three months ended October 31,
	2025		2024
Operating cash outflows from operating leases	$	135,~~780~~028	$	124,~~441~~619
Operating lease assets obtained in exchange for new operating lease liabilities (1)	305,~~964~~975		87,~~903~~630

(1) Includes new leases, acquired leases and remeasurements or modifications of existing leases.

NOTE F — Accumulated Other Comprehensive Loss

Other comprehensive ~~income (~~loss) consists of foreign currency translation adjustments, which includes net investment hedges and long-term intercompany loan translation adjustments, unrealized gains ~~and~~or losses from cash flow hedges, and the unamortized gain or loss on post-retirement plans, net of their related tax effects.

The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the ~~nine~~three months ended ~~April~~October 3031, 2025:

	Unrealized loss on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
	Unrealized (loss) gain on cash flow hedges		Unamortized gain (loss) on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2024	$	(149)	$	462	$	(109,935)	$	(109,622)
Beginning balance, July 31, 2025	$	(394)	$	5	$	(91,770)	$	(92,159)
Other comprehensive (loss) income before reclassification	(716)		—		16,902		16,186
Other comprehensive income before reclassification	618		—		4,743		5,361
Amounts reclassified from accumulated other comprehensive loss	~~156~~222		(~~454~~151)		—		~~(298)~~71
Ending balance, April 30, 2025	$	(709)	$	8	$	(93,033)	$	(93,734)
Ending balance, October 31, 2025	$	446	$	(146)	$	(87,027)	$	(86,727)

The decrease in accumulated other comprehensive loss as of ~~April~~October 3031, 2025 compared to July 31, ~~2024~~2025 was primarily due to ~~the~~ depreciation of the U.S. dollar against certain other currencies during the ~~nine~~three-month period.

The changes in accumulated other comprehensive loss by component, net of tax, for the ~~nine~~three months ended ~~April~~October 3031, 2024 were as follows:

	Unrealized gain on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
	Unrealized loss on cash flow hedges		Unamortized gain on post-retirement plans		Foreign currency translation adjustments		Accumulated other comprehensive loss
Beginning balance, July 31, 2023	$	1,641	$	756	$	(95,458)	$	(93,061)
Beginning balance, July 31, 2024	$	(149)	$	462	$	(109,935)	$	(109,622)
Other comprehensive income (loss) before reclassification	702		—		(12,310)		(11,608)
Other comprehensive loss before reclassification	(1,402)		—		(79)		(1,481)
Amounts reclassified from accumulated other comprehensive loss	(~~1,284~~348)		(~~454~~151)		—		(~~1,738~~499)
Ending balance, April 30, 2024	$	1,059	$	302	$	(107,768)	$	(106,407)
Ending balance, October 31, 2024	$	(1,899)	$	311	$	(110,014)	$	(111,602)

The increase in the accumulated other comprehensive loss as of ~~April~~October 3031, 2024 compared to July 31, ~~2023~~2024 was primarily due to ~~the~~unrealized ~~appreciation~~losses ofon ~~the~~cash ~~U.S.~~flow ~~dollar~~hedges ~~against certain other currencies~~ during the ~~nine~~three-month period.

Of the amounts reclassified from accumulated other comprehensive loss during the ~~nine~~three months ended ~~April~~October 3031, 2025 and 2024, unrealized ~~(losses)~~ gains or losses on cash flow hedges were reclassified to “Cost of goods sold” and unamortized gains or losses on post-retirement plans were reclassified into “Investment and other ~~(expense)~~ income” on the condensed consolidated statements of income.

The following table illustrates the income tax ~~benefit~~ (expense) benefit on the components of other comprehensive ~~income (~~loss) for the three ~~and nine~~ months ended ~~April~~October 3031, 2025 and 2024:

Three months ended April 30,

Nine months ended April 30,

Three months ended October 31,

2025

2024

~~2025~~

~~2024~~

Income tax benefit (expense) related to items of other comprehensive loss:

Income tax (expense) benefit related to items of other comprehensive loss:

Cash flow hedges

~~297~~(77)

~~(51)~~52

~~(106)~~

1110

Table of Contents

NOTE G — Revenue Recognition

The Company recognizes revenue when control of the product or service transfers to the customer at an amount that represents the consideration expected to be received in exchange for those products and services. The Company’s revenues are primarily from the sale of identification and direct part marking solutions, high-performance materials and workplace safety products that are shipped and billed to customers. All revenue is from contracts with customers and is included in “Net sales” on the condensed consolidated statements of income. ~~See Note H, “Segment Information,” for the Company’s disaggregated revenue disclosure.~~

~~The~~Disaggregation ~~Company offers extended warranty coverage that is included in the sales price~~ of certain products, which it accounts for as service warranties. The Company accounts for the deferred revenue associated with extended service warranties as a contract liability. The balance of contract liabilities associated with service warranty performance obligations was $2,986 and $2,947 as of April 30, 2025 and July 31, 2024, respectively. The current portion and non-current portion of contract liabilities are included in “Other current liabilities” and “Other liabilities,” respectively, on the condensed consolidated balance sheets. The Company recognized revenue of $343 and $325 during the three months ended April 30, 2025 and 2024, respectively, and $1,021 and $960 during the nine months ended April 30, 2025 and 2024, respectively, that was included in the contract liability balance at the beginning of the respective period from the amortization of extended service warranties. Of the contract liability balance outstanding at April 30, 2025, the Company expects to recognize 12% by the end of fiscal 2025, an additional 38% by the end of fiscal 2026, and the remaining balance thereafter. Revenue

The following is a summary of net sales by segment and geographic region for the three months ended October 31, 2025:


	Three months ended October 31,
	2025		2024
Net sales:
Americas & Asia
Americas	$	234,049	$	214,033
Asia	34,844		31,395
Total	$	268,893	$	245,428
Europe & Australia
Europe	121,248		116,153
Australia	15,146		15,484
Total	$	136,394	$	131,637

Total Company	$	405,287	$	377,065

Contract Balances

The Company offers extended warranty coverage that is included in the sales price of certain products, which it accounts for as service warranties. The Company accounts for the deferred revenue associated with extended service warranties as a contract liability. The balance of contract liabilities associated with service warranty performance obligations was $3,271 and $3,060 as of October 31, 2025 and July 31, 2025, respectively. The current portion and non-current portion of contract liabilities are included in “Other current liabilities” and “Other liabilities,” respectively, on the condensed consolidated balance sheets. The Company recognized revenue of $374 and $337 during the three months ended October 31, 2025 and 2024, respectively, that was included in the contract liability balance at the beginning of the respective period from the amortization of extended service warranties. Of the contract liability balance outstanding at October 31, 2025, the Company expects to recognize 32% by the end of fiscal 2026, an additional 31% by the end of fiscal 2027, and the remaining balance thereafter.

The Company records deferred revenue for payments received in advance for certain software and services. These amounts are classified as contract liabilities and recognized as revenue over the service period. The balance of contract liabilities related to software and services was $10,178 and $9,246 as of October 31, 2025 and July 31, 2025, respectively. During the three months ended October 31, 2025 and 2024, the Company recognized $2,764 and $2,066 in revenue, respectively, which was previously included in the beginning balance of deferred revenue as of July 31, 2025 and July 31, 2024.

NOTE H — Segment Information

The Company is organized and managed within two regions: Americas & Asia and Europe & Australia, which are the reportable segments. The Company’s Chief Executive Officer (“CEO”), who is also the Company’s Chief Operating Decision Maker (“CODM”), uses segment profit in measuring segment performance, allocating resources, evaluating performance in periodic reviews, and during the development of the annual budget and the regular forecasting process. The CODM considers budget-to-actual variances on a quarterly basis, as well as segment-specific forecasting, when making decisions about the allocation of operating and capital resources to each segment. The CODM also uses the segment’s net sales in measuring segment performance.

~~The following is a summary of net sales by segment and geographic region for the three and nine months ended April 30, 2025 and 2024:~~11

	Three months ended April 30,				Nine months ended April 30,
	2025		2024		2025		2024
Net sales:
Americas & Asia
Americas	$	219,913	$	200,602	$	636,493	$	582,864
Asia	33,739		24,164		96,433		75,171
Total	$	253,652	$	224,766	$	732,926	$	658,035
Europe & Australia
Europe	$	115,715	$	104,925	$	342,345	$	299,629
Australia	13,223		13,693		41,059		40,327
Total	$	128,938	$	118,618	$	383,404	$	339,956
Total Company	$	382,590	$	343,384	$	1,116,330	$	997,991

Table of Contents

The following is a summary of segment ~~profit~~information as of and for the three ~~and nine~~ months ended ~~April~~October 3031, 2025 and 2024:

	Three months ended April 30,				Nine months ended April 30,
	Three months ended October 31,
	2025		2024		~~2025~~		~~2024~~
Segment profit:
Americas & Asia
Americas & Asia	$	57,164	$	49,697	$	158,148	$	143,489
Net sales	$	268,893	$	245,428
Europe & Australia	17,478		19,537		41,872		51,335
Cost of goods sold	131,106		119,178
Total profit from reportable segments	$	74,642	$	69,234	$	200,020	$	194,824
Gross margin	137,787		126,250
Segment expenses:
Research and development	16,715		13,216
Selling, general and administrative	61,209		58,134
Total segment expenses	77,924		71,350
Segment profit	$	59,863	$	54,900
Europe & Australia
Net sales	$	136,394	$	131,637
Cost of goods sold	65,349		68,198
Gross margin	71,045		63,439
Segment expenses:
Research and development	6,577		5,705
Selling, general and administrative	45,736		44,620
Total segment expenses	52,313		50,325
Segment profit	$	18,732	$	13,114
Total profit from reportable segments	$	78,595	$	68,014
Reconciliation to income before income taxes
Total profit from reportable segments	$	78,595	$	68,014
Unallocated costs:
Administrative costs	(10,623)		(9,092)
Investment and other income	1,712		1,234
Interest expense	(1,208)		(1,356)
Income before income taxes	$	68,476	$	58,800
Other Segment Information
Depreciation & amortization:
Americas & Asia	$	7,280	$	6,612
Europe & Australia	3,728		3,552
Total Company	$	11,008	$	10,164
Expenditures for property, plant & equipment:
Americas & Asia	$	8,217	$	4,005
Europe & Australia	2,763		3,281
Total Company	$	10,980	$	7,286

Table of Contents

~~Total~~NOTE ~~profit~~I ~~from~~– ~~reportable~~Stock-Based segments is a measure of operating income that excludes administrative costs related to corporate functions that are otherwise included in the Company's operating income. The following is a reconciliation of total profit from reportable segments to income before income taxes for the three and nine months ended April 30, 2025 and 2024:Compensation

	Three months ended April 30,				Nine months ended April 30,
	2025		2024		2025		2024
Total profit from reportable segments	$	74,642	$	69,234	$	200,020	$	194,824
Unallocated amounts:
Administrative costs	(7,452)		(5,691)		(22,674)		(17,625)
Investment and other (expense) income	(509)		1,596		2,850		4,718
Interest expense	(936)		(728)		(3,604)		(2,284)
Income before income taxes	$	65,745	$	64,411	$	176,592	$	179,633

Incentive Stock Plans

~~NOTE~~The ICompany —has ~~Net~~an ~~Income~~incentive ~~per~~stock plan under which the Board of Directors may grant nonqualified stock options to purchase shares of Class A Nonvoting Common ~~Share~~Stock, restricted stock units (“RSUs”), performance-based restricted stock units (“PRSUs”), or restricted and unrestricted shares of Class A Nonvoting Common Stock to employees and non-employee directors. Certain awards may be subject to pre-established performance goals. The majority of the Company’s annual share-based awards are granted in the first quarter of the fiscal year.

~~Reconciliations~~Total ofstock-based compensation expense recognized during the ~~numerator~~three ~~and~~months ~~denominator~~ended ofOctober ~~the~~31, ~~basic~~2025 and ~~diluted~~2024 ~~per~~was ~~share~~$6,746 ~~computations~~and ~~for~~$5,813, respectively. The total income tax benefit recognized in the ~~Company’s~~condensed ~~Class A~~consolidated statements of income was $1,411 and ~~Class~~$632 Bduring ~~common~~the ~~stock~~three ~~are~~months ~~summarized~~ended asOctober ~~follows:~~31, 2025 and 2024, respectively.

	Three months ended April 30,				Nine months ended April 30,
	2025		2024		2025		2024
Numerator (in thousands):
Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	$	52,263	$	50,890	$	139,380	$	141,759
Less:
Preferential dividends	—		—		(736)		(748)
Preferential dividends on dilutive stock options	—		—		(8)		(5)
Numerator for basic and diluted income per Class B Voting Common Share	$	52,263	$	50,890	$	138,636	$	141,006
Denominator (in thousands):
Denominator for basic income per share for both Class A and Class B	47,644		48,004		47,743		48,294
Plus: Effect of dilutive equity awards	422		382		453		346
Denominator for diluted income per share for both Class A and Class B	48,066		48,386		48,196		48,640
Net income per Class A Nonvoting Common Share:
Basic	$	1.10	$	1.06	$	2.92	$	2.94
Diluted	$	1.09	$	1.05	$	2.89	$	2.91
Net income per Class B Voting Common Share:
Basic	$	1.10	$	1.06	$	2.90	$	2.92
Diluted	$	1.09	$	1.05	$	2.88	$	2.90

Stock Options

~~Potentially~~The ~~dilutive~~stock ~~securities~~options ~~attributable~~issued tounder ~~outstanding~~the ~~stock~~plan ~~options~~have ~~and~~an ~~restricted~~exercise ~~stock~~price ~~units~~equal ~~were~~to ~~excluded from~~ the ~~calculation~~market price of ~~diluted~~the ~~earnings~~Company’s ~~per~~stock ~~share~~at ~~where~~ the ~~combined~~date ~~exercise~~of ~~price~~the grant and ~~average~~generally ~~unamortized~~vest ~~fair~~ratably ~~value~~over ~~were~~three ~~greater~~years, ~~than~~with ~~the~~one-third ~~average~~becoming ~~market~~exercisable ~~price~~one ofyear after the ~~Company's~~grant ~~Class~~date Aand ~~Nonvoting~~one-third ~~Common~~additional ~~Stock~~in ~~because~~each of the ~~effect~~succeeding ~~would~~two ~~have been anti-dilutive~~years. ~~There~~Options ~~were~~issued nounder ~~anti-dilutive~~the ~~shares~~plan, ~~for~~referred ~~the~~to ~~three~~herein ~~months~~as ~~ended~~“time-based” ~~April 30~~options, ~~2025.~~generally ~~The~~expire ~~amount~~ten ofyears ~~anti-dilutive~~from ~~shares~~the ~~were~~date ~~47,409~~of ~~for~~grant. ~~the~~The ~~three~~Company ~~months~~did ~~ended~~not ~~April~~issue ~~30,~~stock ~~2024,~~options ~~and~~in ~~5,759~~its ~~and~~annual ~~136,919~~grant ~~for~~of ~~the~~share-based ~~nine~~awards ~~months~~to ~~ended~~employees ~~April~~in ~~30,~~the ~~2025~~current ~~and~~fiscal ~~2024, respectively~~year.

The following is a summary of stock option activity for the three months ended October 31, 2025:


Time-Based Options	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding at July 31, 2025	1,052,314	$	45.17
Granted	—	—
Exercised	(122,610)	41.22
Forfeited	(712)	54.80
Outstanding at October 31, 2025	928,992	$	45.68	4.6	$	28,192
Exercisable at October 31, 2025	915,638	$	45.56	4.6	$	27,895

The following table summarizes additional stock option information:


	Three months ended October 31,
	2025		2024

Intrinsic value of options exercised during the period (in thousands)	$	4,676	$	4,622
Fair value of options vested during the period (in thousands)	492		1,249
Cash received from the exercise of stock options during the period (in thousands)	5,001		5,855
Tax benefit on options exercised during the period (in thousands)	1,067		1,112

As of October 31, 2025, total unrecognized compensation cost related to stock options was $152 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 0.9 years.

RSUs

RSUs issued under the plan have a grant date fair value equal to the market price of the Company’s stock at the date of grant and generally vest ratably over three years, with one-third vesting one year after the grant date and an additional one-third in each of the succeeding two years.

Table of Contents

~~NOTE~~The Jfollowing —is ~~Fair~~a ~~Value~~summary ~~Measurements~~of RSU activity for the three months ended October 31, 2025:


	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested RSUs as of July 31, 2025	162,667	$	65.19
Granted	97,750	78.19
Vested	(67,719)	61.32
Forfeited	(1,587)	68.21
Non-vested RSUs as of October 31, 2025	191,111	$	73.19

The RSUs granted during the three months ended October 31, 2024 had a weighted-average grant date fair value of $74.63. The total fair value of RSUs vested during the three months ended October 31, 2025 and 2024 was $5,305 and $4,201, respectively.

As of October 31, 2025, total unrecognized compensation cost related to RSUs was $7,524 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 2.3 years.

PRSUs

PRSUs are contingent on the achievement of predetermined market and performance targets. The PRSUs granted under the plan vest at the end of a three-year performance period provided the service period and specified performance targets are met. PRSUs granted during the three months ended October 31, 2025, 2024 and 2023 will vest based on achievement of performance conditions relating to Company revenue and diluted EPS targets.

The PRSUs granted during the three months ended October 31, 2025 had a fair value determined by the average of the high and low stock price on the date of the grant.

The following is a summary of PRSU activity for the three months ended October 31, 2025:


	Number of Shares	Weighted Average Grant Date Fair Value
Non-vested PRSUs as of July 31, 2025	152,266	$	59.92
Granted	73,123	70.14
Vested	(25,074)	60.79
Forfeited	(11,105)	48.62
Non-vested PRSUs as of October 31, 2025	189,210	$	64.19

The PRSUs granted during the three months ended October 31, 2024 had a weighted-average grant date fair value of $71.24. The total fair value of PRSUs vested during the three months ended October 31, 2025 and 2024 was $1,934 and $595, respectively.

As of October 31, 2025, total unrecognized compensation cost related to PRSUs was $8,855 pre-tax, net of estimated forfeitures, which the Company expects to recognize over a weighted-average period of 2.1 years.

Table of Contents

NOTE J — Net Income per Common Share

Reconciliations of the numerator and denominator of the basic and diluted per share computations for the Company’s Class A and Class B common stock are summarized as follows:


	Three months ended October 31,
	2025		2024
Numerator (in thousands):
Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)	$	53,936	$	46,783
Less:
Preferential dividends	(728)		(736)
Preferential dividends on dilutive stock options	(8)		(8)
Numerator for basic and diluted income per Class B Voting Common Share	$	53,200	$	46,039
Denominator (in thousands):
Denominator for basic income per share for both Class A and Class B	47,273		47,732
Plus: Effect of dilutive equity awards	458		485
Denominator for diluted income per share for both Class A and Class B	47,731		48,217
Net income per Class A Nonvoting Common Share:
Basic	$	1.14	$	0.98
Diluted	$	1.13	$	0.97
Net income per Class B Voting Common Share:
Basic	$	1.13	$	0.96
Diluted	$	1.11	$	0.95

Potentially dilutive securities attributable to outstanding stock options and restricted stock units were excluded from the calculation of diluted earnings per share where the combined exercise price and average unamortized fair value were greater than the average market price of the Company’s Class A Nonvoting Common Stock because the effect would have been anti-dilutive. The amount of anti-dilutive shares were 18,468 and 17,278 for the three months ended October 31, 2025 and 2024, respectively.

NOTE K — Fair Value Measurements

In accordance with fair value accounting guidance, the Company determines fair value based on the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The inputs used to measure fair value are classified into the following hierarchy:

Level 1 — Unadjusted quoted prices in active markets for identical instruments that are accessible as of the reporting date.

Level 2 — Other significant pricing inputs that are either directly or indirectly observable.

Level 3 — Significant unobservable pricing inputs, which result in the use of management'’s own assumptions.

The following table summarizes the Company'’s financial assets and liabilities that were accounted for at fair value on a recurring basis asat ~~of April~~October 3031, 2025 and July 31, ~~2024~~2025:

April 30, 2025

July 31, 2024

Fair Value Hierarchy

October 31, 2025

July 31, 2025

Fair Value Hierarchy

Assets:

Deferred compensation plan assets

1819,~~485~~332

2019,~~029~~998

Level 1

Foreign exchange contracts

50534

~~137~~—

Level 2

Liabilities:

Foreign exchange contracts

~~407~~97

~~730~~198

Level 2

The following methods and assumptions were used to estimate the fair value of each class of financial instrument:

Deferred compensation plan assets: The Company’s deferred compensation investments consist of investments in mutual funds, which are included in “Other assets” on the condensed consolidated balance sheets. These investments were classified as Level 1 as the shares of these investments trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis.

Foreign exchange contracts: The Company’s foreign exchange contracts were classified as Level 2 as the fair value was based on the present value of the future cash flows using external models that use observable inputs, such as interest rates, yield curves and foreign exchange rates. See Note K, “Derivatives and Hedging Activities,” for additional information.15

Table of Contents

Foreign exchange contracts: The Company’s foreign exchange contracts were classified as Level 2 as the fair value was based on the present value of the future cash flows using external models that use observable inputs, such as interest rates, yield curves and foreign exchange rates. See Note L, “Derivatives and Hedging Activities,” for additional information.

The fair values of cash and cash equivalents, accounts receivable, accounts payable, and other liabilities approximated carrying values due to their short-term nature.

NOTE KL — Derivatives and Hedging Activities

The Company utilizes forward foreign exchange currency contracts to reduce the exchange rate risk of specific foreign currency denominated transactions. These contracts typically require the exchange of a foreign currency for U.S. dollars at a fixed rate on a future date, with maturities of less than 18 months, which qualify as cash flow hedges or net investment hedges under the accounting guidance for derivative instruments and hedging activities. The primary objective of the Company’s foreign currency exchange risk management program is to minimize the impact of currency movements due to transactions in other than the respective subsidiaries’ functional currency and to minimize the impact of currency movements on the Company’s net investment denominated in a currency other than the U.S. dollar. To achieve this objective, the Company hedges a portion of known exposures using forward foreign exchange currency contracts.

Main foreign currency exposures are related to transactions denominated in the British Pound, Euro, Canadian dollar, Australian dollar, Mexican Peso, Chinese Yuan, Malaysian Ringgit and Singapore dollar. Generally, these risk management transactions will involve the use of foreign currency derivatives to minimize the impact of currency movements on non-functional currency transactions.

The U.S. dollar equivalent notional amounts of outstanding forward exchange contracts were as follows:

	April 30, 2025		July 31, 2024
	October 31, 2025		July 31, 2025
Designated as cash flow hedges	$	1440,~~844~~212	$	5953,~~207~~542
Non-designated hedges	4,~~352~~469		4,~~459~~380
Total foreign exchange contracts	$	1944,~~196~~681	$	6357,~~666~~922

Table of Contents

Cash Flow Hedges

The Company has designated a portion of its forward foreign exchange contracts as cash flow hedges and recorded these contracts at fair value on the condensed consolidated balance sheets. For these instruments, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income (“OCI”) and reclassified into income in the same period or periods during which the hedged transaction affects income. As of ~~April~~October 3031, 2025 and July 31, ~~2024~~2025, unrealized ~~losses~~gains of $~~742~~423 and unrealized losses of $~~124~~493 have been included in OCI, respectively.

Net Investment Hedges

The Company has designated certain third party foreign currency denominated debt borrowed under its credit agreement as net investment hedges. These debt obligations, denominated in Euros and British Pounds, were designated as net investment hedges to hedge portions of the Company'’s net investment in its European operations. The Company’s foreign currency denominated debt obligations are valued under a market approach using publicized spot prices, and the net gains or losses attributable to the changes in spot prices are recorded as cumulative translation within AOCI and are included in the foreign currency translation adjustments section of the condensed consolidated statements of comprehensive income. As of ~~April~~October 3031, 2025 and July 31, ~~2024~~2025, the cumulative ~~balances~~balance recognized in accumulated other comprehensive income were losses of $23,~~850~~023 and $12,~~237~~753, respectively, on any outstanding foreign currency denominated debt obligations.

Table of Contents

The following table summarizes the amount of pre-tax gains and losses related to derivatives designated as hedging instruments:

Three months ended April 30,

Nine months ended April 30,

Three months ended October 31,

2025

2024

~~2025~~

~~2024~~

(Losses) gains recognized in OCI:

Gains (losses) recognized in OCI:

Forward exchange contracts (cash flow hedges)

~~(423)~~621

~~447~~(1,338)

~~(826)~~

~~1,236~~

Foreign currency denominated debt (net investment hedges)

(~~2,883~~270)

~~408~~(190)

~~(1,613)~~

~~947~~

(Losses) gains reclassified from OCI into cost of goods sold

(Losses) gains reclassified from OCI into cost of goods sold:

Forward exchange contracts (cash flow hedges)

(~~210~~296)

~~173~~464

~~(209)~~

~~1,712~~

Fair values of derivative instruments in the condensed consolidated balance sheets were as follows:

	April 30, 2025						July 31, 2024
	October 31, 2025						July 31, 2025
	Prepaid expenses and other current assets		Other current liabilities		Long-term ~~obligations~~Obligations		Prepaid expenses and other current assets		Other current liabilities		Long-term ~~obligations~~Obligations
Derivatives designated as hedging instruments:
Foreign exchange contracts (cash flow hedges)	$	50532	$	~~406~~97	$	—	$	~~137~~—	$	~~726~~197	$	—
Foreign currency denominated debt (net investment hedges)	—		—		34,~~633~~807		—		—		34,~~060~~536
Derivatives not designated as hedging instruments:
Foreign exchange contracts (non-designated hedges)	—2		1—		—		—		41		—
Total derivative instruments	$	50534	$	~~407~~97	$	34,~~633~~807	$	~~137~~—	$	~~730~~198	$	34,~~060~~536

NOTE LM —– Income Taxes

The income tax rate for the three months ended ~~April~~October 3031, 2025 and 2024 was 2021.52% and 2120.04%, respectively. ~~The income tax rate for both of the nine months ended April 30, 2025 and 2024 was 21.1%.~~

15NOTE N — Contingencies

Table of Contents

NOTE M — Contingencies

In the normal course of business, the Company is subject to a variety of investigations, claims, suits, and other legal proceedings, including but not limited to, intellectual property, employment, unclaimed property, tort, and breach of contract matters. Any legal proceedings are subject to inherent uncertainties, and these matters and their potential effects may change in the future. The Company records a liability for contingencies when a loss is deemed to be probable and the loss can be reasonably estimated. The Company currently believes that the outcomes of such proceedings will not have a material adverse impact on its business, financial position, results of operations or cash flows.

NOTE NO — Acquisitions

On August 14, ~~2024~~2025, the Company acquired all of the ~~outstanding~~membership ~~shares~~interest of ~~Gravotech.~~Mecco ~~Headquartered~~for ~~in Lyon~~$19, ~~France~~166, ~~Gravotech~~net isof acash ~~leader~~acquired. inThe ~~the~~purchase ~~design,~~price ~~manufacture~~includes ~~and~~a ~~distribution~~cash payment of ~~innovative~~$17,416 ~~solutions~~and ~~for~~a ~~specialized~~holdback ~~engraving~~liability of $1,750. ~~marking~~Based ~~and~~in ~~cutting~~Pittsburgh, ~~offering laser~~Pennsylvania, ~~mechanical~~Mecco ~~engraving,~~specializes ~~scribing~~in industrial product marking and ~~dot~~identification ~~peen~~systems ~~capabilities~~designed ~~across~~for ~~multiple~~a variety of applications and industries. The acquisition of ~~Gravotech~~Mecco ~~expands~~complements the Company’s ~~identification~~existing ~~product~~offering ~~offerings~~of ~~and~~direct ~~research~~part marking solutions and ~~development~~advances ~~capabilities~~the Company’s strategy to ~~include~~provide ~~specialized~~customers with a variety of end-to-end direct part marking and ~~engraving~~specialty ~~expertise~~identification products. The acquisition was funded through cash on hand. ~~and~~The ~~borrowings~~Company ~~under~~recorded its preliminary purchase price allocation during the ~~Company’s~~first ~~existing~~quarter ~~credit~~of ~~agreement.~~fiscal ~~Net~~year ~~sales~~2026 ~~and~~based ~~net~~on ~~loss~~its ~~attributable~~estimates toof ~~Gravotech~~the ~~from~~fair value of the ~~acquisition~~acquired ~~date~~assets ~~through~~and ~~April~~assumed ~~30,~~liabilities ~~2025~~at ~~were~~that time. The preliminary purchase price allocation included goodwill of $853,~~528~~412, ~~and~~intangible assets of $1014,~~439~~040, ~~respectively~~and net tangible assets of $1,714. The ~~net~~goodwill ~~loss~~for ~~attributable~~this acquisition is assigned to ~~Gravotech~~the Americas & Asia segment and is ~~due~~deductible tofor atax ~~non~~purposes. The final purchase price allocation is subject to post-~~recurring~~closing ~~increase~~adjustments inand ~~cost~~the finalization of ~~goods~~certain ~~sold~~intangible ~~related~~asset tovaluations and deferred tax adjustments. The accompanying condensed consolidated financial statements include the ~~fair~~results ~~value~~of ~~adjustment~~Mecco tofrom ~~inventory~~the ~~upon~~date of acquisition through October 31, 2025. Pro forma and ~~amortization~~other ~~expense~~financial information are not presented for ~~intangible~~the ~~assets~~Mecco acquisition because its impact on the Company’s results of operation and financial position is immaterial.

The preliminary purchase price allocation included goodwill of $69,936 of which $48,586 was assigned to the Americas & Asia segment and $21,350 was assigned to the Europe & Australia segment.

The following table summarizes the preliminary fair value of the assets acquired and liabilities assumed at the date of the acquisition:

Cash and cash equivalents	$	7,469
Accounts receivable, net	23,697
Inventories	21,190
Prepaid expenses and other current assets	549
Property, plant and equipment — net	2,472
Goodwill	69,936
Other intangible assets	64,099
Operating lease assets	6,800
Other assets	1,034
Accounts payable	(17,353)
Accrued compensation and benefits	(9,106)
Taxes, other than income taxes	(6,680)
Accrued income taxes	(1,807)
Other current liabilities	(17,688)
Operating lease liabilities	(6,800)
Other liabilities	(6,729)
Net assets acquired	$	131,083
Less: cash acquired	(7,469)
Fair value of total consideration	$	123,614

The final purchase price allocation is subject to post-closing adjustments pursuant to the terms of the securities sale and purchase agreement, as well as the finalization of certain accounts, primarily intangible assets and deferred tax adjustments. The goodwill for this acquisition is not deductible for tax purposes.

Table of Contents

The following table presents the unaudited pro forma operating results of the Company for the three and nine months ended April 30, 2025 and 2024, reflecting the acquisition of Gravotech as if it had occurred at the beginning of fiscal year 2024. The unaudited pro forma operating results for the three and nine months ended April 30, 2025 do not contain any adjustments to the accompanying condensed consolidated financial statements. The unaudited pro forma operating results for the three and nine months ended April 30, 2024 include Gravotech’s normal operating results and pro forma adjustments to include cumulative expenses, net of tax, for the non-recurring fair value adjustment to inventory, amortization expense for acquired intangible assets and interest expense on acquisition-related debt. The unaudited pro forma operating results are presented for comparative purposes only and do not necessarily reflect future operating results or those that would have occurred had the acquisition been completed at the beginning of fiscal year 2024.

	Three months ended April 30,				Nine months ended April 30,
	2025		2024		2025		2024
Net sales, pro forma	$	382,590	$	371,732	$	1,116,330	$	1,085,253
Net income, pro forma	52,263		48,339		139,380		135,257

On October 1, 2024, the Company acquired all of the outstanding shares of AB&R for $14,827, net of cash acquired. Based in Phoenix, Arizona, AB&R provides integrated solutions for asset tracking, inventory management, and workflow optimization using advanced identification and tracking technologies, including barcoding, radio frequency identification (“RFID”) and Internet of Things (“IoT”)-based systems. The acquisition was funded through cash on hand and borrowings under the Company’s existing credit agreement. The Company recorded its preliminary purchase price allocation during the first quarter of fiscal year 2025, based on its estimates of the fair value of the acquired assets and assumed liabilities at that time. The preliminary purchase price allocation included goodwill of $10,079, intangible assets of $4,600, and net tangible assets of $148. The goodwill for this acquisition is assigned to the Americas & Asia segment and is deductible for tax purposes. The final purchase price allocation is subject to post-closing adjustments and the finalization of certain intangible asset valuations and deferred tax adjustments, as well as potential contingent consideration subject to AB&R’s achievement of certain post-acquisition financial targets pursuant to the terms of the membership interest purchase agreement. Acquisition-related expenses of $305 were recognized in selling, general and administrative (“SG&A”) expenses during the nine months ended April 30, 2025. The accompanying condensed consolidated financial statements include the results of AB&R from the date of acquisition through April 30, 2025. Pro forma and other financial information are not presented for the AB&R acquisition because its impact on the Company's results of operation and financial position is immaterial.

On April 1, 2025, the Company acquired certain assets and liabilities representing the Microfluidic Solutions business unit of Funai Electric Co., Ltd., for $11,648. Headquartered in Lexington, Kentucky, with a manufacturing facility in Cebu, Philippines, Microfluidic Solutions specializes in the research, development and manufacturing of advanced inkjet microfluidic technologies. The acquisition was funded through cash on hand and borrowings under the Company’s existing credit agreement. The Company recorded its preliminary purchase price allocation during the third quarter of fiscal year 2025, based on its estimates of the fair value of the acquired assets and assumed liabilities at that time. The preliminary purchase price allocation included property, plant and equipment of $12,090, inventories of $3,028, other intangible assets of $1,544, accounts payable of $1,111, and other liabilities of $3,903. The final purchase price allocation is subject to post-closing adjustments and the finalization of certain tangible asset valuations, intangible asset valuations and deferred tax adjustments. The accompanying condensed consolidated financial statements include the results of Microfluidic Solutions from the date of acquisition through April 30, 2025. Pro forma and other financial information are not presented for the Microfluidic Solutions acquisition because its impact on the Company's results of operation and financial position is immaterial.

NOTE O — Subsequent Events

On May 15, 2025, the Board of Directors declared a quarterly cash dividend to shareholders of the Company’s Class A and Class B Common Stock of $0.24 per share payable on July 31, 2025, to shareholders of record at the close of business on July 10, 2025.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Brady Corporation is a global manufacturer and supplier of identification and direct part marking solutions, high-performance materials and workplace safety products that identify and protect premises, products and people. The Company is organized and managed on a geographic basis with two reportable segments: Americas & Asia and Europe & Australia. This regional operating structure allows the Company to further integrate its businesses, support continued growth through the application of the best go-to-market strategies in key geographies, facilitate new product development within recent acquisitions and further simplify and scale the global business.

Within each of the reportable segments, the Company markets, sells and distributes a broad range of identification and safety products and solutions across the following primary product categories:

•Safety and facility identification and protection, which includes safety signs, traffic signs and control products, floor-marking tape, pipe markers, labeling systems, spill control products, lockout/tagout devices, personal protection equipment, first aid products, and software and services for safety compliance auditing, procedures writing and training.

•Product identification, which includes materials, printing systems, radio frequency identification (“RFID”) and barcode scanners for product identification, direct part marking, engraving equipment, brand protection labeling, work in process labeling, finished product identification, asset tracking labels, asset tags and industrial track and trace applications.

•Wire identification, which includes handheld printers, wire markers, sleeves, and tags.

•Healthcare identification, which includes wristbands, labels, printing systems, and other products used in hospital, laboratory, and other healthcare settings for tracking and improving the safety of patients.

•People identification, which includes name tags, badges, lanyards, rigid card printing systems, and access control software.

The ability to provide customers with a broad range of proprietary, customized and diverse products for use in various applications across multiple industries and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. Brady'’s long-term sales growth and profitability will depend not only on the overall economic environment and our ability to successfully navigate changes in the macro environment, but also on our ability to develop and market innovative products, deliver a high level of customer service, advance our digital capabilities, and continuously improve the efficiency of our global operations. Our strategy for growth includes an increased focus on certain industries and products, streamlining our product offerings, expanding into higher growth end-markets, intensifying efforts to leverage our diverse product portfolio and synergies across our business, improving the overall customer experience, developing technologically advanced, innovative, and proprietary products, and improving our digital capabilities.

The following are key initiatives supporting our strategy in fiscal ~~2025~~2026:

•Investing in organic growth by enhancing our research and development process and utilizing customer feedback and observations to develop innovative new products that solve customer needs and improve environmental sustainability.

•~~Providing~~Delivering ~~the~~a ~~highest~~high-quality ~~level of~~ customer ~~service~~experience by aligning with customers'’ preferred communications channels and leveraging technology to ~~enhance~~strengthen ~~the customer experience~~engagement.

•Expanding and enhancing ~~our~~ sales capabilities through an improved digital presence and the use of data-driven marketing automation tools.

•Maintaining profitability through pricing mechanisms to mitigate the impacts of ongoing supply chain disruptions and inflationary pressures while ensuring prices ~~are~~remain ~~market~~ competitive.

•Integrating recent acquisitions to ~~further~~ enhance our strategic position and accelerate long-term sales growth.

•~~Driving~~Advancing operational excellence ~~and~~by executing sustainable efficiency gains within our selling, general and administrative structures and within our global operations, including cost reduction initiatives, insourcing of critical products and manufacturing activities, ~~while~~and reducing ~~our~~the Company’s environmental footprint.

•~~Enhancing~~Continuing ~~our~~to build a high-performance culture, which rewards execution, ~~and~~fosters ~~respects diversity~~inclusion, toand ~~elevate~~strengthens employee engagement, ~~and improve~~ recruitment, and retention ~~practices in order to drive differential performance and execute our strategy~~.

Macroeconomic Conditions and Trends

The Company'’s operations and financial performance are subject to the risks and uncertainties inherent in the global economic environment, including inflationary pressures, supply chain disruptions, and other macroeconomic challenges. These pressures may impact the Company'’s business, financial condition and results of operations as the global economic outlook remains uncertain.

Table of Contents

InThe ~~recent~~global ~~months,~~trade ~~the~~environment ~~U.S.~~remains ~~government~~complex ~~introduced~~and ~~incremental~~is ~~import~~rapidly ~~tariffs~~evolving, ondriven ~~goods~~by ~~imported into~~ the ~~U.S.~~imposition ~~from~~of ~~numerous countries, triggering reciprocal~~ tariffs ~~and other actions from many trading partners~~ on goods ~~exported~~entering ~~from~~ the U.S. ~~Trade~~and ~~policies~~countermeasures offrom ~~the U.S. and~~ other ~~countries, including China, are complex and rapidly evolving~~nations. Our ~~strategy of manufacturing products near the point of sale reduces our overall exposure to tariffs, though certain sourced inputs and manufactured items remain subject to incremental tariffs. Our~~ business has incurred, and expects to continue to incur, additional costs as it relates to these incremental tariffs ~~for~~and ~~the~~countermeasures ~~remainder~~for ~~of fiscal 2025 and~~ the foreseeable future. The Company has taken and will continue to take action to mitigate inflationary pressures caused by the incremental tariffs through a combination of targeted price increases and surcharges, strategic sourcing adjustments, product portfolio optimization, as well as our ongoing efforts to drive sustainable efficiency gains in our operations and administrative structures.

Notwithstanding the ~~fluid~~uncertain situation relating to tariffs, we believe our financial strength positions us well to continue investing in acquisitions and organic growth opportunities, such as expanded sales channels, marketing programs, and research and development (“R&D”). We remain focused on driving sustainable efficiency gains and automation across our operations and selling, general and administrative (“SG&A”) functions, while also returning capital to our shareholders through dividends and share repurchases. At ~~April 30~~October 31, 2025, we had cash of $~~152~~182.27 million, as well as a credit agreement with $~~195~~182.20 million available for future borrowing, which can be increased to $1,~~085~~077.20 million at the Company'’s option and subject to certain conditions, for total available liquidity of $1,~~237~~259.47 million.

We believe that our financial resources and liquidity levels, including the undrawn portion of our credit agreement and our ability to increase that credit line as necessary, are sufficient to support the execution of our growth strategy and to manage the impact of economic or geopolitical events that could potentially reduce sales, net income, or cash provided by operating activities. Refer to Risk Factors, included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended July 31, ~~2024~~2025, for further discussion of the possible impact of global economic or geopolitical events on our business.

Results of Operations

The comparability of the operating results for the three ~~and nine~~ months ended ~~April~~October 3031, 2025, compared to the ~~same~~three ~~periods~~months inended ~~the~~October 31, ~~prior~~2024, ~~year~~has ~~have~~ been impacted by ~~the~~ acquisitions of ~~Gravotech~~American onBarcode ~~August~~and 1,RFID ~~2024,~~Incorporated (“AB&R”) on October 1, 2024, ~~and~~the Microfluidic Solutions onbusiness ~~April~~unit 1of Funai Electric Co., ~~2025~~Ltd. ~~The~~(“Microfluidic ~~operating~~Solutions”) ~~results~~on ofApril ~~Gravotech~~1, ~~AB&R~~2025 and ~~Microfluidic~~MECCO ~~Solutions~~Partners ~~have~~LLC ~~been~~(“Mecco”) ~~included~~on ~~since~~August ~~their~~4, ~~acquisition dates~~2025. ~~Gravotech~~The ~~has~~operating ~~been~~results ~~included~~for ineach ~~both~~of ~~reportable~~the ~~segments,~~acquired ~~and~~companies ~~AB&R~~has ~~and Microfluidic Solutions have~~ been included in the Americas & Asia reportable segment. ~~The~~since ~~comparability~~their ofacquisition ~~the year-to-~~date ~~operating results of the Americas & Asia segment has also been impacted by the divestiture of a non-core business in October 2023~~.

A comparison of results of operating income for the three ~~and nine~~ months ended ~~April~~October 3031, 2025 and 2024, is as follows:

	Three months ended April 30,								Nine months ended April 30,
	Three months ended October 31,
(Dollars in thousands)	2025		% Sales		2024		% Sales		~~2025~~		~~% Sales~~		~~2024~~		~~% Sales~~
Net sales	$	~~382~~405,~~590~~287			$	~~343~~377,~~384~~065			$	~~1,116,330~~			$	~~997,991~~
Gross margin	~~195~~208,~~059~~832		51.05	%	~~177~~189,~~027~~689		5150.63	%	~~560,591~~		~~50.2~~	%	~~510,829~~		~~51.2~~	%
Operating expenses:
Research and development	1923,~~191~~292		5.07	%	1718,~~681~~921		5.10	%	~~56,835~~		~~5.1~~	%	~~50,215~~		~~5.0~~	%
Selling, general and administrative	~~108~~117,~~678~~568		2829.40	%	95111,~~803~~846		2729.97	%	~~326,410~~		~~29.2~~	%	~~283,415~~		~~28.4~~	%
Total operating expenses	~~127~~140,~~869~~860		3334.48	%	~~113~~130,~~484~~767		3334.07	%	~~383,245~~		~~34.3~~	%	~~333,630~~		~~33.4~~	%
Operating income	$	67,~~190~~972	1716.68	%	$	6358,~~543~~922	1815.56	%	$	~~177,346~~	~~15.9~~	%	$	~~177,199~~	~~17.8~~	%

References in this Quarterly Report on Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation, sales recorded from acquired companies prior to the first anniversary date of their acquisition, and sales recorded from divested companies up to the first anniversary of their divestiture. The Company'’s organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Net sales for the three months ended ~~April~~October 3031, 2025 increased 117.45% to $~~382~~405.63 million compared to $~~343~~377.41 million in the same period in the prior year. The increase consisted of organic sales growth of 12.68%, ~~and~~ sales growth from acquisitions of 103.52%, ~~which~~and ~~was partially offset by~~ a ~~decrease~~1.5% increase from foreign ~~currency~~ translation ~~of 0~~.~~7%.~~ Organic sales ~~growth~~grew ~~of 5.~~4.7% in the Americas & Asia segment, ~~was~~while ~~partially offset by an~~ organic sales ~~decline~~declined ~~of 5~~0.48% in the Europe & Australia segment ~~during the three months ended April 30, 2025~~ compared to the same period in the prior year.

Gross margin increased 10.1% to $208.8 million in the three months ended October 31, 2025 compared to $189.7 million in the same period in the prior year. As a percentage of net sales, gross margin increased to 51.5% in the three months ended October 31, 2025 compared to 50.3% in the same period in the prior year. The increase in gross margin as a percentage of net sales is primarily driven by the absence of a $4.1 million non-recurring fair value adjustment related to acquisition inventory recorded in the prior-year period, as well as by organic sales growth in higher gross margin product lines. These benefits were partially offset by incremental tariffs in the current three-month period.

Table of Contents

~~Net~~R&D ~~sales~~expenses ~~for~~increased ~~the~~23.1% ~~nine~~to ~~months~~$23.3 ~~ended~~million ~~April~~in ~~30,~~the ~~2025~~three ~~increased~~months ~~11.9%~~ended toOctober $131,~~116.3~~ ~~million~~2025 compared to $~~998~~18.09 million in the same period in the prior year. ~~The~~As ~~increase~~a ~~consisted~~percentage of ~~organic~~net sales, ~~growth~~R&D ofexpenses 2increased to 5.67% ~~and~~in ~~sales~~the ~~growth~~three ~~from~~months ~~acquisitions~~ended ofOctober ~~10.2%~~31, ~~partially~~2025 ~~offset~~compared byto a5.0% ~~decrease~~in ~~from~~the ~~foreign~~same ~~currency~~period ~~translation~~in ofthe 0prior year.5% ~~and~~The aincrease ~~decrease~~in ofR&D ~~0.4%~~spending was primarily due to ainvestments ~~divestiture.~~in ~~Organic~~microfluidic ~~sales~~technologies ~~grew~~and ~~5.0%~~engraving insystems associated with the ~~Americas~~acquisitions &of ~~Asia~~Microfluidic ~~segment~~Solutions and Mecco, ~~while~~and, ~~organic~~to ~~sales~~a ~~declined~~lesser ~~1.9%~~extent, an increase in R&D headcount within the ~~Europe~~Company’s &organic ~~Australia~~business. ~~segment~~The ~~during~~Company ~~the~~remains ~~nine~~committed ~~months~~to ~~ended~~investing ~~April~~in ~~30,~~innovative ~~2025~~product ~~compared~~development to ~~the~~drive ~~same~~long-term ~~period~~organic sales growth. Investments in new printing systems, pressure sensitive materials, engraving systems, microfluidic technologies, scanners and software remain the ~~prior~~primary ~~year~~focus of R&D expenditures in fiscal 2026.

~~Gross~~SG&A ~~margin~~expenses ~~increased~~include ~~10.2%~~selling toand ~~$195.1~~administrative ~~million~~costs indirectly ~~the~~attributed ~~three~~to ~~months~~the ~~ended~~Americas ~~April~~& ~~30,~~Asia ~~2025~~and ~~compared~~Europe to& ~~$177.0~~Australia ~~million~~segments, inas ~~the~~well ~~same~~as ~~period~~certain inother ~~the~~corporate ~~prior~~administrative ~~year.~~expenses Asincluding afinance, ~~percentage~~information ~~of net sales~~technology, ~~gross~~human ~~margin~~resources ~~decreased~~and toother ~~51.0%~~administrative ~~from 51~~expenses.6% inSG&A ~~the~~expenses ~~three-month period. Gross margin~~ increased 95.71% to $~~560~~117.6 million in the ~~nine~~three months ended ~~April~~October 3031, 2025 compared to $~~510~~111.8 million in the same period in the prior year. As a percentage of net sales, ~~gross~~SG&A ~~margin~~ decreased to 5029.20% ~~from 51.2%~~ in the ~~nine-month period. The decrease in gross margin as a percentage of net sales during the~~ three~~-month~~ ~~period~~months ~~was~~ended ~~primarily~~October ~~due~~31, ~~to the impact of incremental tariffs~~2025, ~~primarily~~compared ~~on goods imported~~ to ~~the U~~29.S.7% ~~from~~in ~~China,~~the ~~and~~same ~~$1.1~~period ~~million of facility closure and other reorganization costs, which were partially offset by organic sales growth~~ in ~~higher~~the ~~gross~~prior ~~margin product lines~~year. The decrease in ~~gross~~SG&A ~~margin~~ as a percentage of net sales ~~during~~is ~~the nine months ended April 30, 2025 was~~ primarily due to ~~a non-recurring increase in~~ cost ofreductions ~~goods sold of $4.1 million related to the fair value adjustment to inventory~~ from ~~acquisitions, facility closure and other~~ reorganization ~~costs~~activities ofcompleted ~~$3.0~~in ~~million, as well as~~ the ~~impact~~prior offiscal ~~incremental tariffs, which were partially offset by organic sales growth in higher gross margin product lines~~year.

~~R&D~~Operating ~~expenses~~income increased 815.54% to $1968.20 million in the three months ended ~~April~~October 3031, 2025, compared to $1758.79 million in the same period in the prior year. AsThe aincrease ~~percentage of net sales, R&D expenses decreased to 5.0%~~ in ~~the~~operating ~~three-month~~income ~~period~~was ~~compared~~due to ~~5.1%~~organic insales ~~the~~growth ~~same period~~ in the ~~prior~~Americas ~~year. R~~&D ~~expenses~~Asia ~~increased~~reportable ~~13.2%~~segment, togross ~~$56.8~~margin ~~million~~improvement inacross ~~the~~both ~~nine~~reportable ~~months ended April 30~~segments, ~~2025~~and ~~compared~~SG&A tocost ~~$50.2~~efficiencies ~~million~~ in the ~~same~~Europe ~~period~~& inAsia ~~the prior year~~segment. ~~As a percentage of net sales~~Additionally, ~~R&D~~operating ~~expenses~~income ~~increased~~for tothree ~~5.1%~~months ~~from~~ended ~~5.0%~~October ~~in the nine-month period. The increase in R&D spending was primarily due to the acquisition of Gravotech~~31, ~~and,~~2024 toincluded anon-recurring ~~lesser extent, an increase in R&D headcount within the Company's organic business. The Company remains committed to investing in new product development to drive long~~acquisition-~~term~~related ~~organic sales growth. Investments in new printing systems, materials~~ and ~~new~~other ~~product~~costs ~~development within recent acquisitions are the primary focus~~ of ~~R&D~~$5.1 ~~expenditures in fiscal 2025~~million.

SG&A expenses include selling and administrative costs directly attributed to the Americas & Asia and Europe & Australia segments, as well as certain other corporate administrative expenses including finance, information technology, human resources and other administrative expenses. SG&A expenses increased 13.4% to $108.7 million in the three months ended April 30, 2025 compared to $95.8 million in the same period in the prior year. As a percentage of sales, SG&A expenses increased to 28.4% from 27.9% in the three-month period. SG&A expenses increased 15.2% to $326.4 million for the nine months ended April 30, 2025 compared to $283.4 million in the same period in the prior year. As a percentage of net sales, SG&A expenses increased to 29.2% from 28.4% in the nine-month period. The increase in SG&A expenses during the three and nine months ended April 30, 2025 was primarily due to increased headcount and other selling-related costs from acquisitions, including incremental amortization expense from the acquired intangible assets. Amortization expense increased $2.4 million and $7.1 million during the three and nine months ended April 30, 2025 compared to the same periods in the prior year. SG&A expenses during the three and nine months ended April 30, 2025 also include facility closure and other reorganization costs of $2.8 million and $6.6 million, respectively. SG&A expenses during the nine months ended April 30, 2025 also include non-recurring acquisition-related costs and other expenses of $1.0 million.

Operating income increased 5.7% to $67.2 million and increased 0.1% to $177.3 million in the three and nine months ended April 30, 2025, respectively, compared to $63.5 million and $177.2 million in the same periods in the prior year. The increase in operating income in both the three and nine-month periods was primarily due to organic sales growth in higher gross margin product lines, which was partially offset by non-recurring acquisition-related costs and incremental amortization expense related to acquired businesses, as well as facility closure and other reorganization costs.

Table of Contents

OPERATING INCOME TO NET INCOME

	Three months ended April 30,								Nine months ended April 30,
	Three months ended October 31,
(Dollars in thousands)	2025		% Sales		2024		% Sales		~~2025~~		~~% Sales~~		~~2024~~		~~% Sales~~
Operating income	$	67,~~190~~972	1716.68	%	$	6358,~~543~~922	1815.56	%	$	~~177,346~~	~~15.9~~	%	$	~~177,199~~	~~17.8~~	%
Other (expense) income:
Other income (expense):
Investment and other (expense) income	(509)		(0.1)	%	1,596		0.5	%	2,850		0.3	%	4,718		0.5	%
Investment and other income	1,712		0.4	%	1,234		0.3	%
Interest expense	(~~936~~1,208)		(0.23)	%	(~~728~~1,356)		(0.24)	%	~~(3,604)~~		~~(0.3)~~	%	~~(2,284)~~		~~(0.2)~~	%
Income before income taxes	6568,~~745~~476		1716.29	%	6458,~~411~~800		1815.86	%	~~176,592~~		~~15.8~~	%	~~179,633~~		~~18.0~~	%
Income tax expense	1314,~~482~~540		3.56	%	1312,~~521~~017		3.92	%	~~37,212~~		~~3.3~~	%	~~37,874~~		~~3.8~~	%
Net income	$	5253,~~263~~936	13.73	%	$	5046,~~890~~783	1412.84	%	$	~~139,380~~	~~12.5~~	%	$	~~141,759~~	~~14.2~~	%

Investment and other ~~(expense)~~ income was ~~a net expense of~~ $01.57 million in the three months ended ~~April~~October 3031, 2025 compared to ~~net investment income of~~ $1.~~6 million in the same period in the prior year. Investment and other (expense) income decreased to $~~2.9 million ~~of net investment income~~ in the ~~nine months ended April 30, 2025 compared to $4.7 million in the~~ same period in the prior year. The change ~~in investment and other (expense) income during both the three and nine-month periods~~ was primarily due to ~~the~~an ~~change~~increase in the market value of securities held in deferred compensation plans.

Interest expense ~~increased~~decreased to $01.92 million ~~and~~in ~~$3.6 million for~~ the three ~~and nine~~ months ended ~~April~~October 3031, 2025, ~~respectively,~~ compared to $01.74 million ~~and $2.3 million~~ in the same ~~periods~~period in the prior year. The ~~increase~~decrease in interest expense was primarily due to ana ~~increase~~decrease in the weighted average interest rate on outstanding borrowings on the Company'’s credit agreement toduring ~~fund~~the ~~acquisitions,~~three ~~which~~months ~~was~~ended ~~partially~~October ~~offset~~31, by2025 ~~a decrease in the weighted average interest rate~~ compared to the same ~~periods~~period in the prior year.

The Company'’s income tax rate was 2021.52% and 2120.04% for the three months ended ~~April~~October 3031, 2025 and 2024, respectively~~, and the income tax rate was 21~~.1% for both of the nine-month periods ended April 30, 2025 and 2024. The Company expects its ongoing annual income tax rate to be approximately 21% based on its current global business mix and based on tax laws and statutory rates currently in effect.

Business Segment Operating Results

The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other income, income tax expense, and certain corporate administrative expenses are excluded when evaluating segment performance.

2120

Table of Contents

The following is a summary of segment information for the three ~~and nine~~ months ended ~~April~~October 3031, 2025 and 2024:

	Three months ended April 30,						Nine months ended April 30,
	Three months ended October 31,
	2025			2024			~~2025~~			~~2024~~
SALES GROWTH INFORMATION
Americas & Asia
Organic	5.4.7		%	4.5.1		%	~~5.0~~		%	~~3.0~~		%
Acquisitions	84.69		%	—7.4		%	~~7.9~~		%	—		%
Currency	~~(1.1)~~—		%	(0.12)		%	~~(1.0)~~		%	—		%
Divestiture	—		%	(31.56)		%	~~(0.5)~~		%	~~(3.5)~~		%
Total	~~12.~~9.6		%	010.97		%	~~11.4~~		%	~~(0.5)~~		%
Europe & Australia
Organic	(50.48)		%	40.47		%	~~(1.9)~~		%	~~2.8~~		%
Acquisitions	~~14.2~~—		%	—15.0		%	~~14.2~~		%	—		%
Currency	(04.1)4		%	(03.6)		%	~~(0.1)~~		%	~~1.9~~		%
Total	83.76		%	319.83		%	~~12.8~~		%	~~4.7~~		%
Total Company
Organic	12.68		%	43.56		%	~~2.6~~		%	~~3.0~~		%
Acquisitions	103.52		%	—9.9		%	~~10.2~~		%	—		%
Currency	(01.7)5		%	(01.3)2		%	~~(0.5)~~		%	~~0.6~~		%
Divestiture	—		%	(21.31)		%	~~(0.4)~~		%	~~(2.4)~~		%
Total	117.45		%	113.96		%	~~11.9~~		%	~~1.2~~		%
SEGMENT PROFIT
Americas & Asia	$	5759,~~164~~863		$	4954,~~697~~900		$	~~158,148~~		$	~~143,489~~
Europe & Australia	1718,~~478~~732			1913,~~537~~114			~~41,872~~			~~51,335~~
Total	$	7478,~~642~~595		$	6968,~~234~~014		$	~~200,020~~		$	~~194,824~~
SEGMENT PROFIT AS A PERCENT OF NET SALES
Americas & Asia	22.53		%	22.14		%	~~21.6~~		%	~~21.8~~		%
Europe & Australia	13.67		%	1610.50		%	~~10.9~~		%	~~15.1~~		%
Total	19.54		%	2018.20		%	~~17.9~~		%	~~19.5~~		%

Americas & Asia

Americas & Asia net sales increased ~~12.~~9.6% to $~~253~~268.79 million in the three months ended ~~April~~October 3031, 2025 compared to $~~224~~245.84 million in the same period in the prior year~~, which consisted of organic sales growth of 5~~.4% ~~and~~The ~~sales~~increase growth from acquisitions of 8.6%, which were partially offset by a decrease from foreign currency translation of 1.1%. Americas & Asia net sales increased 11.4% to $732.9 million in the nine months ended April 30, 2025 compared to $658.0 million in the same period in the prior year, which consisted of organic sales growth of 54.07% and sales growth from acquisitions of 74.9%~~, which were partially offset by a decrease from foreign currency translation of 1~~.~~0% and a decrease due to a divestiture of 0.5%.~~

Organic sales in the Americas increased in the ~~low~~mid-single digits in ~~both~~ the three ~~and nine~~ months ended ~~April~~October 3031, 2025 ~~compared to the same periods in the prior year~~. Organic sales growth ~~in both the three and nine-month periods~~ was driven by growth in the wire identification, ~~safety~~ and ~~facility identification and~~ product identification product lines., ~~Organic~~which ~~sales growth~~ was partially offset by an organic sales decline in the ~~people~~safety ~~identification product line in the three months ended April 30, 2025,~~ and anfacility ~~organic sales decline in the healthcare~~ identification product line ~~in the nine months ended April 30, 2025~~.

Organic sales in Asia increased approximately 2312% in the three months ended ~~April~~October 3031, 2025~~, and increased approximately 13% in the nine months ended April 30, 2025 compared to the same periods in the prior year~~. The organic sales increase in the three-month period was realized throughout Asia, ~~which~~with ~~included~~continued ~~a return to organic sales~~ growth infrom ~~China.~~electronics ~~Organic~~manufacturing ~~sales~~services ~~growth~~providers, intechnology ~~the~~companies, ~~nine-month~~and ~~period~~industrial ~~resulted~~suppliers ~~from~~across ~~growth~~Japan, ~~throughout Asia~~India, ~~partially~~Malaysia ~~offset~~and ~~by flat organic sales in China~~Singapore. Organic sales ingrowth ~~both~~was ~~the~~primarily ~~three and nine-month periods were~~ driven by growth in ~~all major product lines, with particularly strong growth in~~ the product identification and safety and facility identification product lines.

~~Americas~~Segment ~~& Asia segment~~ profit increased 159.0% to $5759.29 million in the three months ended ~~April~~October 3031, 2025 compared to $4954.79 million in the same period in the prior year. ~~Segment~~As ~~profit~~a ~~increased~~percentage ~~10.2%~~of tonet ~~$158.1~~sales, ~~million~~segment inprofit ~~the~~was ~~nine~~essentially ~~months~~flat ~~ended~~at ~~April~~22.3% ~~30, 2025~~ compared to ~~$143~~22.54% ~~million~~ in the same period in the prior year. AsThe aincrease ~~percentage~~in ~~of net sales,~~ segment profit ~~increased~~was primarily due to ~~22.5%~~organic ~~from~~sales ~~22.1%~~growth inacross the ~~three-month~~segment. ~~period~~Additionally, ~~and~~ segment profit ~~decreased~~for ~~to 21.6% from 21.8% in~~ the ~~nine-month~~three ~~period~~months ended ~~April 30~~October 31, ~~2025~~2024 ~~compared~~included toacquisition-related ~~the~~costs ~~same~~and ~~periods~~other inpurchase ~~the~~accounting ~~prior year~~adjustments. The decrease in segment profit as a percentage of sales was primarily driven by increased investments in R&D, and to a lesser extent, incremental tariffs in the current three-month period.

Table of Contents

sales was primarily due to costs associated with the closure of two facilities, incremental amortization from acquired businesses and purchase accounting adjustments during the nine-month period, which was partially offset by increased profit from organic sales growth.

Europe & Australia

Europe & Australia net sales increased 83.76% to $~~128~~136.94 million in the three months ended ~~April~~October 3031, 2025 compared to $~~118~~131.6 million in the same period in the prior year~~, which consisted of sales growth from acquisitions of 14~~.2% ~~that~~The ~~was~~increase ~~partially~~reflected ~~offset~~a ~~by an organic sales decline of 5~~4.4% ~~and~~benefit ~~a decrease~~ from foreign currency translation ~~of 0.1%. Europe & Australia net sales increased 12.8% to $383.4 million in the nine months ended April 30~~, ~~2025 compared to $340.0 million in the same period in the prior year,~~ which ~~consisted of sales growth from acquisitions of 14.8%, which~~ was partially offset by an organic sales decline of ~~1.9% and a decrease from foreign currency translation of~~ 0.18%.

Organic sales in Europe declined in the mid-single digits in the three months ended April 30, 2025 and declined in the low-single digits in the nine months ended April 30, 2025 compared to the same periods in the prior year. Organic sales growth in the wire identification product line was more than offset by an organic sales decline in the product identification, safety and facility identification and people identification product lines during both the three and nine-month periods.21

~~Organic~~Table ~~sales~~of in Australia declined in the mid-single digits in both the three and nine months ended April 30, 2025 compared to the same periods in the prior year. The organic sales decline was primarily driven by a decrease in volume in the safety and facility and wire identification product lines.Contents

~~Europe~~Organic &sales ~~Australia segment profit decreased 10.5% to $17.5 million~~ in ~~the~~Europe ~~three~~declined ~~months ended April 30, 2025 compared to $19.5 million~~ in the ~~same~~low-single ~~period~~digits in the ~~prior~~three ~~year. Segment profit decreased 18.4% to $41.9 million in the nine~~ months ended ~~April~~October 3031, 2025. ~~compared~~The toorganic ~~$51.3~~sales ~~million~~decline induring the ~~same~~three-month period inwas ~~the~~primarily ~~prior~~driven ~~year.~~by As a ~~percentage~~decrease ofin ~~net sales, segment profit decreased to 13.6% from 16.5% for~~ the ~~three-month~~people ~~period~~identification and ~~segment~~safety ~~profit~~and ~~decreased~~facility toidentification ~~10.9%~~product ~~from~~lines, ~~15.1%~~which ~~for~~was ~~the~~partially ~~nine-month~~offset ~~period~~by ~~ended~~organic ~~April 30,~~sales ~~2025,~~growth ~~compared~~in to the ~~same~~wire ~~periods~~identification inproduct ~~the prior year~~line. The ~~decrease~~decline ~~in segment profit and segment profit as a percentage of sales~~ was ~~primarily~~driven ~~due~~by tothe ~~incremental~~Middle ~~amortization from acquired businesses~~East, ~~purchase~~the ~~accounting~~United ~~adjustments~~Kingdom and ~~reorganization~~Germany, ~~costs~~which inwas ~~order~~partially tooffset ~~streamline~~by ~~our~~growth ~~operating~~in ~~structure~~France.

Organic sales in Australia increased in the low-single digits in the three months ended October 31, 2025. Organic sales growth was primarily driven by growth in the wire identification product line.

Segment profit increased to $18.7 million in the three months ended October 31, 2025 compared to $13.1 million in the same period of the prior year. As a percentage of net sales, segment profit increased to 13.7% from 10.0% in the same period of the prior year. The increase in segment profit was primarily driven by a more efficient cost structure following reorganization activities completed in the prior fiscal year. Additionally, segment profit for the three months ended October 31, 2024 included acquisition-related costs and other purchase accounting adjustments.

Liquidity and Capital Resources

The Company'’s cash balances are generated and held in numerous locations throughout the world. At ~~April~~October 3031, 2025, 95approximately 99% of the Company'’s cash and cash equivalents were held outside the United States. The Company'’s organic and inorganic growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, research and development, common stock repurchases, and dividend payments for the next 12 months. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.

Cash Flows

Cash and cash equivalents were $~~152~~182.27 million at ~~April~~October 3031, 2025, a decrease of $988.03 million from July 31, ~~2024~~2025. The significant changes were as follows:

	Nine months ended April 30,
	Three months ended October 31,
(Dollars in thousands)	2025		2024
Net cash flow provided by (used in):
Operating activities	$	~~122~~33,~~874~~356	$	~~171~~23,~~094~~406
Investing activities	(~~165~~28,~~079~~388)		(70147,~~331~~901)
Financing activities	~~(52~~2,~~077)~~636		~~(88~~18,~~989)~~263
Effect of exchange rate changes on cash	~~(3,682)~~731		(21,~~848)~~775
Net (decrease) increase in cash and cash equivalents	$	(97,964)	$	8,926
Net increase (decrease) in cash and cash equivalents	$	8,335	$	(104,457)

Net cash provided by operating activities was $~~122~~33.94 million in the ~~nine~~three months ended ~~April~~October 3031, 2025, compared to $~~171~~23.14 million in the same period of the prior year. The ~~decrease~~increase in cash provided by operating activities was primarily due to ~~changes~~improved inprofitability ~~working~~from ~~capital.~~both ~~Increased~~reportable ~~cash outflows related to inventory were primarily due to new product launches and the timing of facility moves during the nine months ended April 30, 2025~~segments. ~~Additionally, higher cash outflows related to accounts payable in the current year were primarily driven by normalization of outstanding payables from acquired businesses.~~

23Net cash used in investing activities was $28.4 million in the three months ended October 31, 2025, primarily reflecting the acquisition of a business for $17.4 million and capital expenditures of $11.0 million. Net cash used in investing activities was $147.9 million in the three months ended October 31, 2024, primarily reflecting acquisition of businesses totaling $140.6 million and capital expenditures of $7.3 million.

~~Table~~Net cash provided by financing activities was $2.6 million in the three months ended October 31, 2025, compared to $18.3 million of ~~Contents~~net cash used in financing activities in the same period of the prior year. The change was primarily driven by lower net borrowings and, to a lesser extent, increased share repurchases during the three months ended October 31, 2025 compared to the same period in the prior year.

Net cash used in investing activities was $165.1 million in the nine months ended April 30, 2025, which primarily consisted of the acquisition of businesses of $147.2 million and capital expenditures of $18.7 million. Net cash used in investing activities was $70.3 million in the nine months ended April 30, 2024, which primarily consisted of capital expenditures including the purchase of a previously leased facility in Mexico and facility construction costs in Belgium.

Net cash used in financing activities was $52.1 million in the nine months ended April 30, 2025 compared to $89.0 million in the same period in the prior year. The decrease in cash used in financing activities was primarily due to a decline in share repurchases compared to the same period in the prior year.

Material Cash Requirements

Our material cash requirements for known contractual obligations include capital expenditures, repayment of borrowings on our credit agreement and lease obligations. We believe that net cash provided by operating activities will continue to be adequate to meet our liquidity and capital needs for these items over the next 12 months and in the long-term beyond the next 12 months. We also have cash requirements for purchase orders and contracts for the purchase of inventory and other goods and services, which are based on current and anticipated customer needs and are fulfilled by our suppliers within short time horizons. We do not have significant agreements for the purchase of inventory or other goods or services specifying minimum ~~order quantities. In addition, we may have liabilities for uncertain tax positions, but we do not believe that the cash requirements to meet any of these liabilities will be material.~~

Table of Contents

order quantities. In addition, we may have liabilities for uncertain tax positions, but we do not believe that the cash requirements to meet any of these liabilities will be material.

Credit Agreement

On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency credit agreement with a group of five banks.

On November 14, 2022, the Company and certain of its subsidiaries entered into a second amendment to the credit agreement to, among other items, (a) increase the lending commitments by $100 million for total lending commitments of $300 million, (b) extend the final maturity date to November 14, 2027, (c) increase the interest rate on certain borrowings by 0.125%, and (d) increase the available amount under the credit agreement, at the Company'’s option and subject to certain conditions, from $300 million up to (i) an amount equal to the incremental borrowing necessary to bring the Company'’s consolidated net debt-to-EBITDA ratio as defined in the credit agreement to 2.5 to 1.0 plus (ii) $200 million.

On October 10, 2024, the Company and certain of its subsidiaries entered into a ~~Third~~third ~~Amendment~~amendment to ~~Credit Agreement (“Amendment No. 3”) with a group of six banks, which amended~~ the ~~original~~ credit agreement ~~dated August 1, 2019. Amendment No. 3 amended the credit agreement~~ to, among other ~~things~~items, change the applicable benchmark ~~under~~rate ~~the credit agreement~~ for borrowings denominated in Canadian Dollars ~~from the Canadian Dollar Offered Rate (“CDOR”) to the adjusted Term Canadian Overnight Repo Rate Average Rate (“CORRA”). Borrowings~~ under ~~Amendment No. 3 are unsecured and are guaranteed by certain of~~ the ~~Company's~~credit ~~domestic subsidiaries~~agreement.

As of ~~April~~October 3031, 2025, the outstanding balance on the Company'’s credit agreement was $~~102~~115.89 million. The maximum amount outstanding on the credit agreement during the ~~nine~~three months ended ~~April 30~~October 31, 2025 was $~~144~~119.86 million. As of ~~April~~October 3031, 2025, the U.S. dollar-denominated borrowings of $4254.05 million bear interest at 5.30%; the Euro-denominated borrowings of €44.0 million bear interest at 3.2.8%; and the British Pound-denominated borrowings of £8.0 million bear interest at 54.38%. The Company had letters of credit outstanding under the credit agreement of $2.01 million as of ~~April~~October 3031, 2025, and there was $~~195~~182.20 million available for future borrowing, which can be increased to $1,~~085~~077.20 million at the Company'’s option, subject to certain conditions. The credit agreement has a final maturity date of November 14, 2027. As such, borrowings were classified as long-term on the condensed consolidated balance sheets.

Covenant Compliance

The Company'’s credit agreement requires it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the debt agreements, of not more than a 3.5 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of ~~April~~October 3031, 2025, the Company was in compliance with these financial covenants, with a ratio of debt to EBITDA, as defined by the agreements, equal to 0.34 to 1.0 and the interest expense coverage ratio equal to 7170.58 to 1.0.

Forward-Looking Statements

In this ~~quarterly~~Quarterly ~~report~~Report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company'’s future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

24The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:

~~Table~~•Increased cost of ~~Contents~~raw materials, labor, material shortages and supply chain disruptions, including as a result of tariffs or other impacts of the global trade environment

~~The~~•Decreased ~~use~~demand offor ~~words~~the such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady'Company’s ~~control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:~~products

•~~Increased~~Ability ~~cost~~to ofcompete ~~materials,~~effectively ~~labor, material shortages and supply chain disruptions, including as a result of tariffs~~ or ~~other~~to ~~impacts~~successfully ofexecute the ~~global~~Company’s ~~trade environment~~strategy

•Decreased demand for the Company's products

•Ability to compete effectively or to successfully execute the Company's strategy

•Ability to develop technologically advanced products that meet customer demands

•Ability to identify, integrate, and grow acquired companies~~, and to manage contingent liabilities from divested businesses~~

•Difficulties in protecting websites, networks, and systems against security breaches and difficulties in preventing phishing attacks, social engineering or malicious break-ins

•Risks associated with the loss of key employees

•Global climate change and environmental regulations

•Litigation, including product liability claims

•Global climate change and environmental regulations

•Foreign currency fluctuations

Table of Contents

•Changes in tax legislation and tax rates

•Potential write-offs of goodwill and other intangible assets

•Differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures

•Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady'’s U.S. Securities and Exchange Commission (“SEC”) filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady'’s Form 10-K for the year ended July 31, ~~2024~~2025.

These uncertainties may cause Brady'’s actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Refer to the Company’s annual report on Form 10-K for the year ended July 31, ~~2024~~2025. There has been no material change in this information since the ~~2024~~2025 Form 10-K.

ITEM 4. CONTROLS AND PROCEDURES

Brady Corporation maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer (the “Chief Executive Officer”) and its Chief Financial Officer, Chief Accounting Officer and Treasurer (the “Chief Financial Officer”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.

There were no changes in the Company'’s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company'’s most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company'’s internal control over financial reporting.

2524

Table of Contents

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The information set forth in Note MN, "“Contingencies"” included in this Quarterly Report on Form 10-Q is incorporated herein by reference.

ITEM 1A. RISK FACTORS

The Company’s business, results of operations, financial condition, and cash flows are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of Company’s Annual Report on Form 10-K for the year ended July 31, ~~2024~~2025. There have been no material changes from the risk factors set forth in the ~~2024~~2025 Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The Company maintains a share repurchase program for the Company'’s Class A Nonvoting Common Stock. The program may be implemented by purchasing shares in the open market or in privately negotiated transactions, with repurchased shares available for use in connection with the Company'’s stock-based plans and for other corporate purposes.

On September 4, 2024, the Company'’s Board of Directors authorized an increase in the Company'’s share repurchase program, authorizing the repurchase of an additional $100.0 million of the Company'’s Class A Nonvoting Common Stock, which expanded upon the Company'’s prior authorization for a total authorized amount of $137.8 million. The share repurchase program may be implemented from time to time on the open market or in privately negotiated transactions and has no expiration date. As of ~~April~~October 3031, 2025, there ~~was~~were $~~104~~82.6 9 million worth of ~~repurchase~~shares ~~authority~~authorized to purchase remaining pursuant to the existing share repurchase program.

The following table provides information with respect to the purchases by the Company of Class A Nonvoting Common Stock during the three months ended ~~April~~October 3031, 2025:

Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(Dollars in Thousands)
February 1, 2025 - February 28, 2025	45,148	$	72.31	45,148	$	134,524
August 1, 2025 - August 31, 2025	—	$	—	—	$	86,951
March 1, 2025 - March 31, 2025	264,170	70.59		264,170	115,877
September 1, 2025 - September 30, 2025	—	—		—	86,951
April 1, 2025 - April 30, 2025	166,760	67.43		166,760	104,633
October 1, 2025 - October 31, 2025	55,010	73.69		55,010	82,897
Total	~~476~~55,~~078~~010	$	6973.6469	~~476~~55,~~078~~010	$	~~104~~82,~~633~~897

ITEM 5. OTHER INFORMATION

During the three months ended ~~April~~October 3031, 2025, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is identified in Item 408(a) of Regulation S-K.

2625

Table of Contents

ITEM 6. EXHIBITS

Exhibit No.						Exhibit Description
10.1						Change of Control Agreement between Brady Corporation and Andrew T. Gorman dated as of September 16, 2025 (incorporated by reference to Exhibit 10.1 in Registrant’s Current Report on Form 8-K dated September 16, 2025)*
31.1						Rule 13a-14(a)/15d-14(a) Certification of Russell R. Shaller
31.2						Rule 13a-14(a)/15d-14(a) Certification of Ann E. Thornton
32.1						Section 1350 Certification of Russell R. Shaller
32.2						Section 1350 Certification of Ann E. Thornton
101.INS						Inline XBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.)
101.SCH						Inline XBRL ~~Taxonomy~~ Extension Taxonomy Schema Document
101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE						Inline XBRL Taxonomy Extension Presentation Label Linkbase Document
104						Cover Page Interactive Data File (Formatted as Inline XBRL contained in Exhibit 101)

27* Management contract or compensatory plan or arrangement

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

BRADY CORPORATION

Date: May 16, 2025

/s/ RUSSELL R. SHALLER

Date: November 17, 2025

/s/ RUSSELL R. SHALLER

Russell R. Shaller

President and Chief Executive Officer

(Principal Executive Officer)

Date: May 16, 2025

/s/ ANN E. THORNTON

Date: November 17, 2025

/s/ ANN E. THORNTON

Ann E. Thornton

Chief Financial Officer, Chief Accounting Officer and Treasurer

(Principal Financial Officer and Principal Accounting Officer)

2827

Filing Compare · BRADY CORP